Transglutaminase 2 in human diseases
Zsolt Sarang
BioMedicine, 2017
View PDFchevron_right
The cellular response to transglutaminase-cross-linked collagen
Victoria Addy
Biomaterials, 2005
View PDFchevron_right
Prognostic role of tissue transglutaminase 2 in colon carcinoma
Sofia Ángel Torres
Virchows Archiv, 2016
View PDFchevron_right
Tissue transglutaminase: a new target to reverse cancer drug resistance
Alfredo Budillon
Amino Acids, 2013
View PDFchevron_right
Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer
SANTOSH KUMAR
Breast Cancer Research, 2012
View PDFchevron_right
Identification of Tissue Transglutaminase as a Novel Molecule Involved In Human CD8+ T Cell Transendothelial Migration
Bela Rex-Kiss
The Journal of Immunology, 2003
View PDFchevron_right
The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2
Nicoletta Bianchi
Cells
View PDFchevron_right
Tissue transglutaminase promotes or suppresses tumors depending on cell context
Kapil Mehta
Anticancer research, 2009
View PDFchevron_right
Keratinocyte transglutaminase expression varies in squamous cell carcinomas
Scott Thacher
Journal of investigative …, 1994
View PDFchevron_right
Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells
Kapil Mehta
2006
View PDFchevron_right
Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence
Jasmeet Assi
2016
View PDFchevron_right
Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast Cancer
Kapil Mehta
Clinical Cancer Research, 2004
View PDFchevron_right
Study of tumor transglutaminase 2 expression in gallbladder cancer – Is it a novel predictor of survival?
Jatinder Kaur
Annals of Hepato-Biliary-Pancreatic Surgery, 2020
View PDFchevron_right
Review transglutaminases: part II—industrial applications in food, biotechnology, textiles and leather products
Carla Matte
World Journal of Microbiology and Biotechnology, 2019
View PDFchevron_right
Tissue transglutaminase: An emerging target for therapy and imaging
Jens Pietzsch
Bioorganic & Medicinal Chemistry Letters, 2013
View PDFchevron_right
The Outside-In Journey of Tissue Transglutaminase in Cancer
Livia E. Sima
Cells
View PDFchevron_right
The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression
Simone Beninati
Medical Sciences
View PDFchevron_right
Interaction of tissue transglutaminase with nuclear transport protein importin-α3
Mark Levitt
FEBS Letters, 1999
View PDFchevron_right
ChemInform Abstract: Tissue Transglutaminase: An Emerging Target for Therapy and Imaging
Jens Pietzsch
ChemInform, 2014
View PDFchevron_right
Tissue transglutaminase: from biological glue to cell survival cues
Kapil Mehta
2006
View PDFchevron_right
Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells
SANTOSH KUMAR
Breast Cancer Research, 2012
View PDFchevron_right
Transglutaminases: key regulators of cancer metastasis
Simone Beninati
Amino Acids, 2012
View PDFchevron_right
Transglutaminases: part I—origins, sources, and biotechnological characteristics
Carla Matte
World Journal of Microbiology and Biotechnology, 2020
View PDFchevron_right
Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells
Chithan Kandaswami, Jiuan-Jiuan Hwang
Molecular Cancer, 2011
View PDFchevron_right
Expression of Transglutaminase 5 in Normal and Pathologic Human Epidermis
alessandro terrinoni
Journal of Investigative Dermatology, 2002
View PDFchevron_right
The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling
Kiran Bhadriraju
Biomaterials, 2009
View PDFchevron_right
Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation
C. Brancolini
Cell Death and Differentiation, 1999
View PDFchevron_right
Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype
Nicoletta Bianchi
International Journal of Molecular Sciences
View PDFchevron_right
Article Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer
Thư Nguyễn
2015
View PDFchevron_right
Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells
Kapil Mehta
Oncogene, 2006
View PDFchevron_right
Tissue transglutaminase-mediated chemoresistance in cancer cells
Amit Verma
Drug Resistance Updates, 2007
View PDFchevron_right
Tissue transglutaminase activity protects from cutaneous melanoma metastatic dissemination: an in vivo study
Simone Beninati
View PDFchevron_right
Cross-linking transglutaminases with G protein-coupled receptor signaling
Siiri Iismaa
2006
View PDFchevron_right